Jagsonpal Pharmaceuticals Limited Share Price and Company Fundamentals

• Overview
• Annual Report
• Balance Sheet
• Cash Flow
• Insider Transactions

Last traded: Last Saturday at 6:59 AM

Jagsonpal Pharmaceuticals Limited engages in the manufacture and trading of pharmaceutical products and active pharmaceutical ingredients in the areas in the areas of women health, pain and analgesics, and general medicine in India and internationally. It offers pharmaceutical formulations and over the counter drugs in the areas of gynaecology, orthopaedics, and allergy management. It offers drugs in the form of tablets, softgels, injections, capsules, and syrups. The company was incorporated in 1978 and is headquartered in New Delhi, India.

Key Metrics

Company profile

Dividends

Jagsonpal Pharmaceuticals Limited paid ₹0.00 dividend and the ex-dividend date was 21 Aug 2023.The dividend payout ratio is 53.82%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.JAGSNPHARM dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

JAGSNPHARM's forward dividend amount is ₹5 and the forward dividend yield is 1.40%. A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of May 2024, following are the company executives and directors listed on Jagsonpal Pharmaceuticals Limited.

Profitability and management effectiveness

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Jagsonpal Pharmaceuticals Limited is and its enterprise value is .

The JAGSNPHARM's stocks Beta value is 0.99 making it 1% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM) Frequently Asked Questions

1. What is Jagsonpal Pharmaceuticals Limited's Stock Symbol?

Jagsonpal Pharmaceuticals Limited trades on NSE under the ticker symbol "JAGSNPHARM".

2. What is Jagsonpal Pharmaceuticals Limited's stock price today?

One share of JAGSNPHARM stock can currently be purchased for approximately ₹356.

3. How can I contact Jagsonpal Pharmaceuticals Limited?

Jagsonpal Pharmaceuticals Limited's mailing address is T-210 J, Shahpur Jat New Delhi 110049 India. The company can be reached via phone at 91 12 4440 6710.

4. What is Jagsonpal Pharmaceuticals Limited's official website?

The official website of Jagsonpal Pharmaceuticals Limited is https://www.jagsonpal.com.